To Our Friends & Supporters

Many thanks for your continuing support of the Juvenile Bipolar Research Foundation. All progress we make is attributable to your extraordinarily consistent generosity.

Your contributions have helped fund research that has resulted in ground‐breaking studies that identified a novel subtype, and an effective treatment for the most severe form of juvenile‐onset bipolar disorder (referred to as the Fear of Harm subtype). The research led to a major expansion of knowledge in the field.

Recruiting for Treatment Study – video

This is a video that documents the experiences of three children who have participated in the pilot study of intranasal ketamine as a treatment for juvenile bipolar disorder. Dr. Demitri Papolos, Director of Research for JBRF, developed and implemented a pilot study to explore the efficacy of intranasal ketamine as a treatment for children who…

JBRF Genetic Study

The Goal The goal of the Genetics Study is to better understand the genetic basis of juvenile bipolar disorder.  Greater comprehension of the biological basis of the disorder will lead to better methods of prevention and treatment. Genetics 101 The human body is composed of trillions of cells.  Each one of these cells contains chromosomes.…

Ketamine clinical study kicks off!

A targeted treatment for children struggling with bipolar disorder. JBRF received approval from the U.S. Food and Drug Administration (“FDA”) to begin the clinical trial of a pharmaceutical agent to treat the symptoms of bipolar disorder in children. The clinical trial will study the efficacy and safety of the use of intranasal ketamine in the…